Relief Therapeutics Holding SA (RLFTF)
1.46
-0.01
(-0.68%)
USD |
OTCM |
May 24, 16:00
Relief Therapeutics Total Assets (Quarterly): 90.95M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 90.95M |
| June 30, 2023 | 139.87M |
| June 30, 2023 | 139.87M |
| December 31, 2022 | 203.63M |
| June 30, 2022 | 232.44M |
| June 30, 2022 | 232.44M |
| December 31, 2021 | 275.26M |
| June 30, 2021 | 195.42M |
| June 30, 2021 | 195.42M |
| December 31, 2020 | 89.33M |
| June 30, 2020 | 36.11M |
| June 30, 2020 | 36.11M |
| December 31, 2019 | 20.50M |
| June 30, 2019 | 31.78M |
| June 30, 2019 | 31.78M |
| December 31, 2018 | 36.13M |
| June 30, 2018 | 35.49M |
| June 30, 2018 | 35.49M |
| December 31, 2017 | 31.79M |
| June 30, 2017 | 32.64M |
| June 30, 2017 | 32.64M |
| December 31, 2016 | 30.88M |
| Date | Value |
|---|---|
| June 30, 2016 | 23.35M |
| June 30, 2016 | 23.35M |
| December 31, 2015 | 0.0132M |
| June 30, 2015 | 34.09M |
| June 30, 2015 | 34.09M |
| December 31, 2014 | 42.09M |
| June 30, 2014 | 46.65M |
| June 30, 2014 | 46.65M |
| December 31, 2013 | 52.70M |
| June 30, 2013 | 1.154M |
| June 30, 2013 | 1.154M |
| December 31, 2012 | 42.93M |
| June 30, 2012 | 1.382M |
| June 30, 2012 | 1.382M |
| December 31, 2011 | 46.42M |
| June 30, 2011 | 14.37M |
| December 31, 2010 | 62.37M |
| June 30, 2010 | 57.38M |
| December 31, 2009 | 62.98M |
| June 30, 2009 | 70.72M |
| December 31, 2008 | 71.73M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
20.50M
Minimum
Dec 2019
275.26M
Maximum
Dec 2021
130.06M
Average
139.87M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| AC Immune SA | 185.40M |
| CRISPR Therapeutics AG | 2.439B |
| Addex Therapeutics Ltd | 5.526M |
| NLS Pharmaceutics Ltd | 1.847M |
| Molecular Partners AG | 205.71M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.77M |
| Shareholders Equity (Quarterly) | 62.18M |
| Debt to Equity Ratio | 0.0066 |
| Current Ratio | 2.649 |
| Net Debt Paydown Yield | 0.01% |